Top-News

LabStyle Innovations News

Aktie
WKN:  A2AFAE ISIN:  US50544T3023
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
42,77 Mio.
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 18.10.2015

LabStyle Innovations News

21.06.22 - PR Newswire
DarioHealth Announces New Contract with a National Employer
DarioHealth Announces New Contract with a National Employer PR Newswire
15.06.22 - PR Newswire
Solera Health Adds DarioHealth to Its Cardiometabolic Network to Offer Hypertension Management Solutions
Solera Health Adds DarioHealth to Its Cardiometabolic Network to Offer Hypertension Management Solutions PR Newswire
09.06.22 - PR Newswire
DarioHealth Secures $50 Million Dollar Non-Dilutive Credit Facility with OrbiMed
DarioHealth Secures $50 Million Dollar Non-​Dilutive Credit Facility with OrbiMed PR Newswire
03.06.22 - PR Newswire
DarioHealth Presents Three New Studies Demonstrating Improved Health in Users with Multiple Conditions at the American Diabetes Association's 82nd Scientific Sessions
DarioHealth Presents Three New Studies Demonstrating Improved Health in Users with Multiple Conditions at the American Diabetes Association's 82nd Scientific Sessions PR ...
19.05.22 - PR Newswire
DarioHealth Announces Additional Commercial Contracts for its Digital Therapeutic Solutions
DarioHealth Announces Additional Commercial Contracts for its Digital Therapeutic Solutions PR Newswire
12.05.22 - PR Newswire
DarioHealth Reports Record Quarterly Revenues in its 2022 First Quarter
DarioHealth Reports Record Quarterly Revenues in its 2022 First Quarter PR Newswire
04.05.22 - PR Newswire
DarioHealth to Report First Quarter 2022 Results on Thursday, May 12
DarioHealth to Report First Quarter 2022 Results on Thursday, May 12 PR Newswire
27.04.22 - PR Newswire
DarioHealth Presents New Clinical Research Demonstrating Improved Outcomes for Participants Using a Single Integrated Digital Solution to Manage Multiple Chronic Conditions
DarioHealth Presents New Clinical Research Demonstrating Improved Outcomes for Participants Using a Single Integrated Digital Solution to Manage Multiple Chronic Conditions ...
14.04.22 - PR Newswire
DarioHealth Announces Agreement with Health Plan Colorado Access
DarioHealth Announces Agreement with Health Plan Colorado Access PR Newswire
23.03.22 - PR Newswire
DarioHealth Announces Additional New Employer Contracts
DarioHealth Announces Additional New Employer Contracts Dario continues rapid expansion of employer business across multi-​condition suite of solutions PR Newswire
22.03.22 - PR Newswire
DarioHealth Reports Fourth Quarter and Full Year 2021 Results and Operational Highlights
DarioHealth Reports Fourth Quarter and Full Year 2021 Results and Operational Highlights Transformational year delivered strong revenue growth of 190% quarter-​over-quarter and ...
14.03.22 - PR Newswire
DarioHealth to Report Fourth Quarter and Full Year 2021 Results on Monday, March 21
DarioHealth to Report Fourth Quarter and Full Year 2021 Results on Monday, March 21 Company to host conference call and webcast on Tuesday, March 22, at 8:30 am ET PR ...
09.03.22 - PR Newswire
DarioHealth Announces Two New Contracts within the Employer and Provider Market
DarioHealth Announces Two New Contracts within the Employer and Provider Market New clients continue Dario's track record of success in winning employer and provider ...
07.03.22 - PR Newswire
DarioHealth to Participate in the Cowen 42nd Annual Healthcare Conference
DarioHealth to Participate in the Cowen 42nd Annual Healthcare Conference PR Newswire
01.03.22 - PR Newswire
DarioHealth Enters into Strategic Agreement with Sanofi U.S.
DarioHealth Enters into Strategic Agreement with Sanofi U.S. Novel Strategic Agreement Focuses on Commercial Growth for Dario and the Development of Digital Health Solutions ...
09.02.22 - PR Newswire
DarioHealth Publishes Clinical Outcomes Demonstrating the Impact of Using a Single Digital Therapeutics Platform for Multiple Conditions
DarioHealth Publishes Clinical Outcomes Demonstrating the Impact of Using a Single Digital Therapeutics Platform for Multiple Conditions New peer-​reviewed study sheds light on ...
08.02.22 - PR Newswire
DarioHealth Announces Four New Employer Contracts
DarioHealth Announces Four New Employer Contracts New contracts expand Dario's footprint to more than 40 clients in the employer market PR Newswire
20.01.22 - PR Newswire
DarioHealth Enters Agreement to Acquire Physimax, a Leading Provider of Validated Computer Vision for Musculoskeletal Health
DarioHealth Enters Agreement to Acquire Physimax, a Leading Provider of Validated Computer Vision for Musculoskeletal Health Dario's third all-​equity acquisition in the last 12 ...
19.01.22 - PR Newswire
DarioHealth Enters into Agreement with Large Regional Health Plan
DarioHealth Enters into Agreement with Large Regional Health Plan New Partnership Expands Dario's Payer Presence with First Contract for Managed Medicaid PR Newswire
18.01.22 - PR Newswire
DarioHealth to Host Investor Webinar on Navigating Emerging Digital Health Trends for Strategic Growth in 2022
DarioHealth to Host Investor Webinar on Navigating Emerging Digital Health Trends for Strategic Growth in 2022 Webinar to be held Wednesday, January 19th at 8am ET PR Newswire

Newssuche

Videos

newspaper
07.05.24 +6,80%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »